HomeBusinessAbbvie raises sales outlook of two immunology drugs to more than $17.5 billion in 2025A sign stands outside a Abbvie facility in Cambridge Estimated read time 1 min read A sign stands outside a Abbvie facility in Cambridge A sign stands outside a Abbvie facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder
